NCT00696488

Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Wake Forest University · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this research study is to measure adherence to the study drug (Carac) for the treatment of actinic keratoses.

Detailed description

The purpose of this research study is to measure adherence to the study drug for the treatment of actinic keratoses. The study drug is 5-Fluorouracil (Carac®); it will be used in this study to treat actinic keratoses on the face and anterior scalp. This proposed study will evaluate adherence to topical Carac® in 20 adults age 50 or greater with actinic keratoses from a clinic population. Adherence data will be collected by the MEMS cap (Medication Event Monitoring System

Conditions

• Actinic Keratosis

Interventions

Type	Name	Description
DRUG	Fluorouracil 0.5%	Subjects will apply the smallest amount of study medication possible that is just sufficient to cover all of the affected areas daily to AK lesions

Timeline

• Start date: 2007-04-01
• Primary completion: 2007-08-01
• Completion: 2008-10-01
• First posted: 2008-06-12
• Last updated: 2018-09-10
• Results posted: 2017-03-27

Locations

1 site across 1 country: United States